New York, NY, United States of America

Anatoly Ruvinsky

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Aconcagua Bio, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anatoly Ruvinsky. Retrieved from https://idiyas.com/inventor/anatoly-ruvinsky-x672x34p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Anatoly Ruvinsky

Introduction

Anatoly Ruvinsky is a notable inventor based in New York, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of receptor activity modulation. His work focuses on developing compounds that can effectively treat conditions associated with calcitonin and amylin receptor activity.

Latest Patents

Ruvinsky holds a patent for "Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity." This patent provides innovative compounds aimed at modulating the activity of these receptors. The pharmaceutical compositions derived from his research are designed to treat diseases or disorders linked to calcitonin and amylin receptor activity. He has 1 patent to his name.

Career Highlights

Anatoly Ruvinsky is currently associated with Aconcagua Bio, Inc., where he continues to advance his research and development efforts. His expertise in receptor activity has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Ruvinsky has collaborated with notable colleagues, including Hui Lei and Cui Li, to further enhance the impact of his research. Their combined efforts contribute to the innovative solutions being developed at Aconcagua Bio, Inc.

Conclusion

Anatoly Ruvinsky's work exemplifies the importance of innovation in the pharmaceutical field. His contributions to receptor activity modulation are paving the way for new treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…